Category Law & Policy
Enacting Pharmaceutical Transparency – Who, What, How, When, & Why
Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists, and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.
Gene editing: a chance to think about diversity
Jackie Leach Scully calls for a wide-ranging discussion of the scope and nature of human genetic variation and diversity.
The Human Germline Genome Editing Debate
Charis M Thompson summarizes the recent debate on human germline gene editing and calls for a broader and more inclusive public discussion.
